News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MerLion Pharmaceuticals Pte Ltd And ICES Ink R&D Partnership To Boost Singapore'S Bio-Technology Industry



5/31/2006 5:57:43 PM

The Institute of Chemical and Engineering Sciences (ICES), a research institute under the Agency for Science, Technology and Research, signed a research collaboration agreement with MerLion Pharmaceuticals Pte Ltd to synthesise and develop novel molecules, based upon naturally derived compounds, for anti-tumour drug therapies. The agreement was signed by Dr Tony Buss, President and CEO of MerLion and Dr Keith Carpenter, Executive Director of ICES.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES